Global Peanut Allergy Therapeutics Competitive Landscape Professional Research Report 2025
Description
Global Peanut Allergy Therapeutics Competitive Landscape Professional Research Report 2025
Research Summary
Peanut allergy therapeutics refer to medical treatments and interventions developed to address peanut allergies, which are potentially life-threatening immune reactions to peanuts. These therapeutics aim to reduce the severity of allergic reactions or, in some cases, desensitize individuals with peanut allergies, allowing them to tolerate peanuts without experiencing severe symptoms. Immunotherapy, such as oral immunotherapy (OIT) and sublingual immunotherapy (SLIT), is a common approach, where individuals are gradually exposed to small, controlled amounts of peanut allergen to build tolerance. In some cases, biologics like monoclonal antibodies that target specific immune pathways involved in allergic responses are also being explored as treatment options. Peanut allergy therapeutics are critical for improving the quality of life and safety of individuals with peanut allergies by potentially reducing the risk of accidental exposure and severe allergic reactions.
According to DIResearch's in-depth investigation and research, the global Peanut Allergy Therapeutics market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Peanut Allergy Therapeutics include Mylan, Bayer, UCB Pharma, Johnson & Johnson, Perrigo, GSK, Kaleo, Amneal Pharma, ALK Abello, Aimmune Therapeutics, HUAPONT Pharm, Sanofi, ASIT Biotech, Allergy Therapeutics, DBV Technologies, HAL Allergy, Intrommune Therapeutics etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Peanut Allergy Therapeutics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Peanut Allergy Therapeutics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Peanut Allergy Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peanut Allergy Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Peanut Allergy Therapeutics Include:
Mylan
Bayer
UCB Pharma
Johnson & Johnson
Perrigo
GSK
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
HUAPONT Pharm
Sanofi
ASIT Biotech
Allergy Therapeutics
DBV Technologies
HAL Allergy
Intrommune Therapeutics
Peanut Allergy Therapeutics Product Segment Include:
Epinephrine Injection
Antihistamines
Oral Immunotherapy
Other
Peanut Allergy Therapeutics Product Application Include:
Adults
Children
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Peanut Allergy Therapeutics Industry PESTEL Analysis
Chapter 3: Global Peanut Allergy Therapeutics Industry Porter’s Five Forces Analysis
Chapter 4: Global Peanut Allergy Therapeutics Major Regional Market Size and Forecast Analysis
Chapter 5: Global Peanut Allergy Therapeutics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Peanut Allergy Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Peanut Allergy Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Peanut Allergy Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Peanut Allergy Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Peanut Allergy Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Peanut Allergy Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Peanut Allergy Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Peanut Allergy Therapeutics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Peanut Allergy Therapeutics Product by Type
- 1.2.1 Epinephrine Injection
- 1.2.2 Antihistamines
- 1.2.3 Oral Immunotherapy
- 1.2.4 Other
- 1.3 Peanut Allergy Therapeutics Product by Application
- 1.3.1 Adults
- 1.3.2 Children
- 1.4 Global Peanut Allergy Therapeutics Market Size Analysis (2020-2032)
- 1.5 Peanut Allergy Therapeutics Market Development Status and Trends
- 1.5.1 Peanut Allergy Therapeutics Industry Development Status Analysis
- 1.5.2 Peanut Allergy Therapeutics Industry Development Trends Analysis
- 2 Peanut Allergy Therapeutics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Peanut Allergy Therapeutics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Peanut Allergy Therapeutics Market Analysis by Regions
- 4.1 Peanut Allergy Therapeutics Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Peanut Allergy Therapeutics Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Peanut Allergy Therapeutics Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Peanut Allergy Therapeutics Revenue Forecast by Region (2026-2032)
- 5 Global Peanut Allergy Therapeutics Market Size by Type and Application
- 5.1 Global Peanut Allergy Therapeutics Market Size by Type (2020-2032)
- 5.2 Global Peanut Allergy Therapeutics Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Peanut Allergy Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Peanut Allergy Therapeutics Market Size by Type
- 6.4 North America Peanut Allergy Therapeutics Market Size by Application
- 6.5 North America Peanut Allergy Therapeutics Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Peanut Allergy Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Peanut Allergy Therapeutics Market Size by Type
- 7.4 Europe Peanut Allergy Therapeutics Market Size by Application
- 7.5 Europe Peanut Allergy Therapeutics Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Peanut Allergy Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Peanut Allergy Therapeutics Market Size by Type
- 8.4 China Peanut Allergy Therapeutics Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Peanut Allergy Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Peanut Allergy Therapeutics Market Size by Type
- 9.4 APAC (excl. China) Peanut Allergy Therapeutics Market Size by Application
- 9.5 APAC (excl. China) Peanut Allergy Therapeutics Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Peanut Allergy Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Peanut Allergy Therapeutics Market Size by Type
- 10.4 Latin America Peanut Allergy Therapeutics Market Size by Application
- 10.5 Latin America Peanut Allergy Therapeutics Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Peanut Allergy Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Peanut Allergy Therapeutics Market Size by Type
- 11.4 Middle East & Africa Peanut Allergy Therapeutics Market Size by Application
- 11.5 Middle East & Africa Peanut Allergy Therapeutics Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Peanut Allergy Therapeutics Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Peanut Allergy Therapeutics Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Peanut Allergy Therapeutics Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Mylan
- 13.1.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Mylan Peanut Allergy Therapeutics Product Portfolio
- 13.1.3 Mylan Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Bayer
- 13.2.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Bayer Peanut Allergy Therapeutics Product Portfolio
- 13.2.3 Bayer Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 UCB Pharma
- 13.3.1 UCB Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 UCB Pharma Peanut Allergy Therapeutics Product Portfolio
- 13.3.3 UCB Pharma Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Johnson & Johnson
- 13.4.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Johnson & Johnson Peanut Allergy Therapeutics Product Portfolio
- 13.4.3 Johnson & Johnson Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Perrigo
- 13.5.1 Perrigo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Perrigo Peanut Allergy Therapeutics Product Portfolio
- 13.5.3 Perrigo Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 GSK
- 13.6.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 GSK Peanut Allergy Therapeutics Product Portfolio
- 13.6.3 GSK Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Kaleo
- 13.7.1 Kaleo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Kaleo Peanut Allergy Therapeutics Product Portfolio
- 13.7.3 Kaleo Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Amneal Pharma
- 13.8.1 Amneal Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Amneal Pharma Peanut Allergy Therapeutics Product Portfolio
- 13.8.3 Amneal Pharma Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 ALK Abello
- 13.9.1 ALK Abello Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 ALK Abello Peanut Allergy Therapeutics Product Portfolio
- 13.9.3 ALK Abello Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Aimmune Therapeutics
- 13.10.1 Aimmune Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Aimmune Therapeutics Peanut Allergy Therapeutics Product Portfolio
- 13.10.3 Aimmune Therapeutics Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 HUAPONT Pharm
- 13.11.1 HUAPONT Pharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 HUAPONT Pharm Peanut Allergy Therapeutics Product Portfolio
- 13.11.3 HUAPONT Pharm Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Sanofi
- 13.12.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Sanofi Peanut Allergy Therapeutics Product Portfolio
- 13.12.3 Sanofi Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 ASIT Biotech
- 13.13.1 ASIT Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 ASIT Biotech Peanut Allergy Therapeutics Product Portfolio
- 13.13.3 ASIT Biotech Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 Allergy Therapeutics
- 13.14.1 Allergy Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Allergy Therapeutics Peanut Allergy Therapeutics Product Portfolio
- 13.14.3 Allergy Therapeutics Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.15 DBV Technologies
- 13.15.1 DBV Technologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 DBV Technologies Peanut Allergy Therapeutics Product Portfolio
- 13.15.3 DBV Technologies Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.16 HAL Allergy
- 13.16.1 HAL Allergy Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 HAL Allergy Peanut Allergy Therapeutics Product Portfolio
- 13.16.3 HAL Allergy Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.17 Intrommune Therapeutics
- 13.17.1 Intrommune Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.17.2 Intrommune Therapeutics Peanut Allergy Therapeutics Product Portfolio
- 13.17.3 Intrommune Therapeutics Peanut Allergy Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Peanut Allergy Therapeutics Industry Chain Analysis
- 14.2 Peanut Allergy Therapeutics Industry Raw Material and Suppliers Analysis
- 14.2.1 Peanut Allergy Therapeutics Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Peanut Allergy Therapeutics Typical Downstream Customers
- 14.4 Peanut Allergy Therapeutics Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
